| Aminolevulinic acid-photodynamic therapy | ALA-PDT |
| Antigen-presenting cells | APC |
| Ataxia-telangiectasia mutated | ATM |
| Adenosine triphosphate | ATP |
| B7 protein family dendritic cell molecule | B7-DC |
| Bristol Mayers Squibb 202 | BMS-202 |
| Bursa of Fabricius cells | B cell |
| Calreticulin | CRT |
| Chemokine (C-X-C motif) ligand 2 | CXCL2 |
| Cluster of differentiation 8 | CD8 |
| Cytotoxic T lymphocyte | CTL |
| Cytotoxic T lymphocyte antigen 4 | CTLA4 |
| Damage-associated molecular patterns | DAMP |
| Damage-regulated autophagy modulator | DRAM |
| Dendritic cells | DC |
| Draining lymph nodes | DLN |
| External beam radiation therapy | EBRT |
| Forkhead box P3 | FoxP3 |
| Genetically engineered mouse model | GEMM |
| Glysated chitosan | GC |
| Gold nanorod | GNR |
| Gold nanostar | GNS |
| Granulocyte-macrophage colony-stimulating factor (GM-CSF)-transfected tumor cell vaccine | GVAX |
| Head and neck squamous cell carcinoma | HNSCC |
| Heat shock proteins | HSP |
| High mobility group box 1 | HMGB1 |
| Immune checkpoint blockade | ICB |
| Immune checkpoint inhibition | ICI |
| Immunogenic cell death | ICD |
| Indoleamine-pyrrole 2,3-dioxygenase | IDO |
| Interferon | IFN |
| Interferon gamma | IFNγ |
| Interleukin 1 beta | IL-1β |
| Interleukin 6 | IL-6 |
| Interleukin 12 | IL-12 |
| Interleukin 17 | IL-17 |
| Ionizing radiation | IR |
| Lymphocyte-activation gene 3 | LAG3 |
| Lipopolysaccharide | LPS |
| Monoclonal antibodies | mAbs |
| Macrophage inflammatory protein 2 | MIP2 |
| Magnetic Fe3O4 photothermal nanoparticle | MNP |
| Major histocompatibility complex I and II | MHC I and II |
| MHC class I polypeptide-related sequence A | MICA |
| Myeloid-derived suppressor cells | MDSC |
| Natural killer | NK |
| Natural killer group 2D | NKG2D |
| Near-infrared radiation | NIR |
| Non-small-cell lung carcinoma | NSCLC |
| Organic semiconducting pro-nano stimulant | OSPS |
| Pancreatic ductal adenocarcinoma | PDAC |
| Pattern recognition receptors | PRR |
| Photodynamic therapy | PDT |
| Photosensitizer | PS |
| Photothermal agents | PTA |
| Photothermal therapy | PTT |
| Poly(lactic-co-glycolic) acid-indocyanine green-R837 | PLGA-ICG-R837 |
| Programmed cell death protein 1 | PD1/PDCD1 |
| Programmed cell death protein 1 ligand 1 | PDL1 |
| Prussian blue nanoparticle | PBNP |
| Radiation therapy | RT |
| Reactive oxygen species | ROS |
| Regulatory T cells | Treg |
| Renal cell carcinoma | RCC |
| Stereotactic body radiation therapy | SBRT |
| Small-cell lung cancer | SCLC |
| Single-walled carbon nanotubes | SWCNT |
| Silica–gold nanoshell | AuNS |
| T cell receptor | TCR |
| T helper 17 | Th17 |
| T lymphocytes | T cell |
| Toll-like receptors | TLR |
| Transforming growth factor beta | TGFβ |
| Tumor-associated macrophages | TAM |
| Tumor microenvironment | TME |
| Tumor necrosis factor alpha | TNFα |
| Tumor neoantigens | TNA |
| Tumor-specific antigens | TSA |
| Urothelial carcinoma | UC |
| Vascular endothelial growth factor | VEGF |